GlassScriptPhysician profile
Jerry K Izu
NPI 1407928039
$14,100.67
in general payments reported to CMS, 2019-2025
36 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $438 · 2021: $791 · 2022: $770 · 2023: $813 · 2024: $9,477 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Food and Beverage: $1,717 · Consulting Fee: $1,600 · Travel and Lodging: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Food and Beverage | $1,716.77 |
| Consulting Fee | $1,600.00 |
| Travel and Lodging | $790.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,393.96 | 2024 | |
| Mimedx Group, INC. | $1,600.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $1,578.97 | 2019-2025 | |
| Exeltis, USA INC. | $278.88 | 2020-2024 | Slynd, Solosec |
| Mayne Pharma Commercial LLC | $242.97 | 2022-2025 | |
| Allergan, INC. | $171.93 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $165.21 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $143.99 | 2019-2020 | |
| Myovant Sciences INC. | $141.24 | 2022 | |
| Organon LLC | $136.72 | 2022-2025 | Nexplanon |
| Therapeuticsmd, INC. | $123.93 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $106.34 | 2019-2020 | |
| Evofem Biosciences, INC. | $98.10 | 2020-2023 | Phexxi |
| Horizon Therapeutics Plc | $88.66 | 2019-2021 | |
| Hologic Sales and Service, LLC | $83.77 | 2022-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $80.38 | 2023-2024 | |
| Coopersurgical, INC. | $68.47 | 2019-2025 | Paragard T 380a |
| Astellas Pharma US INC | $66.19 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $59.42 | 2019-2020 | |
| Sage Therapeutics, LLC | $51.36 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $45.91 | 2021-2022 | |
| Daiichi Sankyo INC. | $42.06 | 2021 | |
| Ascend Therapeutics US, LLC | $39.38 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.40 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $35.61 | 2021 | |
| Duchesnay USA Incorporated | $32.23 | 2019 | |
| Millicent US INC | $25.00 | 2025 | Femlyv, Intrarosa |
| Vertex Pharmaceuticals Incorporated | $24.90 | 2025 | |
| Zyla Life Sciences, INC. | $24.70 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.92 | 2022 | |
| Mission Pharmacal Company | $17.23 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $17.19 | 2023 | Vivjoa |
| Exact Sciences Corporation | $16.42 | 2025 | The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $15.47 | 2024 | |
| Lupin INC. | $15.11 | 2019 | |
| Channel Medsystems, INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Izu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.